Defa25, an alpha-defensin 25, is predicted to enable protein homodimerization activity and plays a multifaceted role in various processes, including antimicrobial humoral immune responses, innate immune responses in mucosa, and defense responses to bacteria. Located in the extracellular region, Defa25 is orthologous to human genes DEFA3 and DEFA6, indicating its importance in the intricate network of innate immune defense.
Activation of Defa25 involves a complex interplay of signaling pathways and cellular processes. Chemicals such as retinoic acid, butyrate, and sulforaphane directly or indirectly activate Defa25 by modulating specific pathways. Retinoic acid, for instance, binds to retinoic acid receptors, enhancing Defa25 expression crucial for antimicrobial humoral immune responses and innate immune defense in mucosa. Indirect activators like EGCG and berberine impact AMPK and PI3K/Akt pathways, respectively, enhancing Defa25 expression and supporting its role in extracellular defense against bacteria. These chemicals contribute to the intricate regulatory mechanisms governing Defa25 activation, highlighting the sophisticated nature of innate immune responses and mucosal defense mechanisms orchestrated by this alpha-defensin.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $43.00 $65.00 $200.00 $815.00 | 6 | |
Amide form of Vitamin B3, indirectly activating Defa25 through SIRT1 modulation. Enhances the expression of Defa25 by influencing cellular processes related to antimicrobial humoral immune responses. Promotes the protein's involvement in the extracellular space, supporting its role in mucosal defense mechanisms against bacteria. Exhibits anti-inflammatory effects and impacts pathways associated with innate immune responses in mucosa, contributing to Defa25 function. | ||||||